Home >  Search by Antibiotics > Puromycin

Puromycin

 
Cell line Species Tissue Culture medium Cencentration
293 human kidney; fetal Dulbecco's modified Eagle's medium 3 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 1.50 (μg/ml)
CHO hamster, Chinese ovary Ham’s F-12 nutrient mixture 2 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 1 (μg/ml)
HCC Dulbecco's modified Eagle's medium 0.6 (μg/ml)
293 human kidney; fetal RPMI 1640 Medium 2 (μg/ml)
CNE-1 Dulbecco's modified Eagle's medium 1 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 1 (μg/ml)
HCT-15 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 5 (μg/ml)
HMEC-1 Dulbecco's modified Eagle's medium 1 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 2 (μg/ml)
SCC Dulbecco's modified Eagle's medium 1500 (μg/ml)
B35 rat central nervous system; nitrosoethylurea-induced neuroblastoma Dulbecco's modified Eagle's medium 200 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 2 (μg/ml)
Hep G2 human liver; hepatocellular carcinoma Minimal essential medium 3 (μg/ml)
L-M(TK-) mouse subcutaneous connective tissue (areolar and adipose) Dulbecco's modified Eagle's medium 2 (μg/ml)
SK-N-MC human supraorbital area (metastasis); neuroepithelioma (brain primary) Dulbecco's modified Eagle's medium 5 (μg/ml)
NCI-H1299 human lymph node (metastasis); large cell neuroendocrine carcinoma (lung primary) RPMI 1640 Medium 1 (μg/ml)
Capan-1 human liver (metastasis); adenocarcinoma (pancreas primary) RPMI 1640 Medium 2 (μg/ml)
MDCK (NBL-2) dog kidney Dulbecco's modified Eagle's medium 3 (μg/ml)
Calu-3 human pleural effusion (metastasis); adenocarcinoma (lung primary) Earle’s balanced salt solution medium 2 (μg/ml)
Calu-3 human pleural effusion (metastasis); adenocarcinoma (lung primary) Earle’s balanced salt solution medium 2 (μg/ml)
3T3 mouse embryonic fibroblast Dulbecco's modified Eagle's medium 0.5 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 0.5 (μg/ml)
LLC-PK1 pig kidney Dulbecco's modified Eagle's medium 0.5 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 0.5 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 0.5 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 0.5 (μg/ml)
RK3E rat kidney Dulbecco's modified Eagle's medium 2 (μg/ml)
JEG-3 human placenta; choriocarcinoma 1.875 (μg/ml)
MCF 10A human mammary gland; fibrocystic disease DMEM + F12 medium 2 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Dulbecco's modified Eagle's medium 2 (μg/ml)
CHO-K1 hamster, Chinese ovary 2.5 (μg/ml)
BRL 3A rat liver Dulbecco's modified Eagle's medium 0.5 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 0.8 (μg/ml)
BRL 3A rat liver Dulbecco's modified Eagle's medium 0.8 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 1 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 0.8 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 2 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Dulbecco's modified Eagle's medium 2 (μg/ml)
NCI-H1299 human lymph node (metastasis); large cell neuroendocrine carcinoma (lung primary) 2 (μg/ml)
HBL-100 RPMI 1640 Medium 2 (μg/ml)
3T3 mouse embryonic fibroblast 2 (μg/ml)
3T3 mouse embryonic fibroblast 2 (μg/ml)
HeLa human cervix; adenocarcinoma 2 (μg/ml)
MDA-MB-435 human breast Dulbecco's modified Eagle's medium 2 (μg/ml)
MDA-MB-468 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Dulbecco's modified Eagle's medium 2 (μg/ml)
MDA-MB-231 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) RPMI 1640 Medium 0.5 (μg/ml)
CHO-K1 hamster, Chinese ovary DMEM + F12 medium 5 (μg/ml)
293T/17 human kidney; highly transfective DMEM + F12 medium 1 (μg/ml)
DG75 RPMI 1640 Medium 10 (μg/ml)
TW01 DMEM + F12 medium 10 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney α-modified minimal essential medium 10 (μg/ml)
A20 mouse B lymphocyte; reticulum cell sarcoma RPMI 1640 Medium 1 (μg/ml)
Hep3B Dulbecco's modified Eagle's medium 2 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Minimal essential medium 2 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 2 (μg/ml)
Sf9 armyworm, fall ovary TC-100 medium 10 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 12.5 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 2 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 2 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 1 (μg/ml)
CHO-K1 hamster, Chinese ovary 3 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 2 (μg/ml)
ST pig testis 5 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 2.5 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 0.25 (μg/ml)
BALB/3T3 Dulbecco's modified Eagle's medium 2 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 2 (μg/ml)
CHO hamster, Chinese ovary RPMI 1640 Medium 0.5 (μg/ml)
SCC-9 human tongue; squamous cell carcinoma 50 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 50 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 50 (μg/ml)
hES BG01V human variant of human embryonic stem cell line BG01 DMEM / F 12 medium 0.5 (μg/ml)
A253 human epidermis; epidermoid carcinoma DMEM + F12 medium 0.5 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 2 (μg/ml)
Saos-2 human bone; osteosarcoma Dulbecco's modified Eagle's medium 1 (μg/ml)
BJAB Dulbecco's modified Eagle's medium 2 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 2 (μg/ml)
ES-E14TG2a mouse embryonic stem cell; pluripotent; HGRPT deficient 5 (μg/ml)
CHO-K1 hamster, Chinese ovary Minimal essential medium 0.3 (μg/ml)
A20 mouse B lymphocyte; reticulum cell sarcoma RPMI 1640 Medium 3 (μg/ml)
HeLa human cervix; adenocarcinoma 0.5 (μg/ml)
HCT-15 human colon; colorectal adenocarcinoma RPMI 1640 Medium 2 (μg/ml)
SW480 human colon; colorectal adenocarcinoma RPMI 1640 Medium 0.5 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia Dulbecco's modified Eagle's medium 0.3 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 2.5 (μg/ml)
K-562 human pleural effusion (metastatic); chronic myelo-genous leukemia (bone marrow primary) RPMI 1640 Medium 1.5 (μg/ml)
NIH/3T3 mouse embryo 0.5 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Dulbecco's modified Eagle's medium 1 (μg/ml)
CHO-K1 hamster, Chinese ovary RPMI 1640 Medium 7.5 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 7.5 (μg/ml)
U-2 OS human bone; osteosarcoma Dulbecco's modified Eagle's medium 1 (μg/ml)
DT40 chicken bursa; lymphoma RPMI 1640 Medium 0.5 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 0.125 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 2 (μg/ml)
32D Clone 3 mouse bone marrow RPMI 1640 Medium 5 (μg/ml)
32D Clone 3 mouse bone marrow 10 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 3.5 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 1.5 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 1.5 (μg/ml)
32D Clone 3 mouse bone marrow RPMI 1640 Medium 0.5 (μg/ml)
Hep G2 human liver; hepatocellular carcinoma 1 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 0.4 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 0.3 (μg/ml)
293 human kidney; fetal 0.3 (μg/ml)
COS-7 monkey, African green kidney Dulbecco's modified Eagle's medium 0.3 (μg/ml)
tsBN7 Dulbecco's modified Eagle's medium 2 (μg/ml)
InRIG9 RPMI 1640 Medium 5 (μg/ml)
INS-1 RPMI 1640 Medium 2 (μg/ml)
U251 Dulbecco's modified Eagle's medium 2.5 (μg/ml)
SD1 RPMI 1640 Medium 2.5 (μg/ml)
BJAB RPMI 1640 Medium 4 (μg/ml)
D54-MG Dulbecco's modified Eagle's medium 2 (μg/ml)
16HBE 5 (μg/ml)
H4IIEC3 Dulbecco's modified Eagle's medium 2 (μg/ml)
T47-D Dulbecco's modified Eagle's medium 0.75 (μg/ml)
HT-29 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 1 (μg/ml)
CL1.0 RPMI 1640 Medium 0.6 (μg/ml)
300-19 pre-B RPMI 1640 Medium 0.25 (μg/ml)
MDCK dog kidney Dulbecco's modified Eagle's medium 1.5 (μg/ml)
GH3 rat pituitary tumor Ham's F-10 1.5 (μg/ml)
GT1-7 Dulbecco's modified Eagle's medium 1.5 (μg/ml)
IOSE-80PC 1 (μg/ml)
NPA Ham’s F-12 nutrient mixture 1 (μg/ml)
ARO Ham’s F-12 nutrient mixture 1 (μg/ml)
HCT-8/S11 1 (μg/ml)
S108L 2 (μg/ml)
LβT2 Dulbecco's modified Eagle's medium 1 (μg/ml)
T47DC42 Minimal essential medium 0.8 (μg/ml)
DKO-1 Dulbecco's modified Eagle's medium 3 (μg/ml)
HTR-8/SVneo RPMI 1640 Medium 4 (μg/ml)
IB-RS-2 Dulbecco's modified Eagle's medium 2 (μg/ml)
PC-2 RPMI 1640 Medium 5 (μg/ml)
 
 
 
This project is supported byTOKU-Ewhich specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
 Cell-Lines | Plasmids | Privacy Policy | Terms of Use | About Us | Contact Us
Cell-Culture Database Version 1.1